Pricing a hurdle for next-gen devices, but Canadian robotics company says change is coming

“These are one-time treatments that hopefully have curative effects and that’s exactly what all of us in society should want,” Sarepta Therapeutics CEO Doug Ingram told FierceBiotech last summer. “The interesting thing is, the healthcare system is going to have to evolve and embrace these things.” On the device side, there are a number of players working on robotic exoskeletons to help paralyzed people walk again.